| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/03/2001 | WO2001031006A2 Serum amyloid a isoform from colostrum |
| 05/03/2001 | WO2001031005A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 05/03/2001 | WO2001031003A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 05/03/2001 | WO2001030999A1 Salt tolerance genes |
| 05/03/2001 | WO2001030987A2 Tankyrase h, compositions involved in the cell cycle and methods of use |
| 05/03/2001 | WO2001030985A1 Tailored peptide synthetases, a method for their production and the use thereof |
| 05/03/2001 | WO2001030972A2 Regulation of gene expression by neuroleptic agents |
| 05/03/2001 | WO2001030853A1 Antibody against rat postacrosome reaction sperm and utilization thereof |
| 05/03/2001 | WO2001030849A1 Dna molecules encoding l-glutamate-gated chloride channels from schistocerca americana |
| 05/03/2001 | WO2001030846A1 Beta-defensins |
| 05/03/2001 | WO2001030844A1 Dna encoding human alpha1g-c t-type calcium channel |
| 05/03/2001 | WO2001000666A3 Self-aligning peptides derived from human elastin and other fibrous proteins |
| 05/03/2001 | WO2000063245A3 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant |
| 05/03/2001 | CA2389522A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 05/03/2001 | CA2389256A1 Beta-defensins |
| 05/03/2001 | CA2389110A1 Regulation of gene expression by neuroleptic agents |
| 05/03/2001 | CA2389031A1 Dna encoding human alpha1g-c t-type calcium channel |
| 05/03/2001 | CA2388637A1 Human fgf-20 gene and gene expression products |
| 05/03/2001 | CA2388617A1 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 05/03/2001 | CA2388599A1 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 05/03/2001 | CA2388332A1 Tankyrase h, compositions involved in the cell cycle and methods of use |
| 05/03/2001 | CA2388162A1 Dna molecules encoding l-glutamate-gated chloride channels from schistocerca americana |
| 05/03/2001 | CA2387907A1 Serum amyloid a isoform from colostrum |
| 05/03/2001 | CA2384972A1 Tailor-made peptide synthetases, methods for their preparations and their use |
| 05/02/2001 | EP1096162A1 Split spool type flexible coupling |
| 05/02/2001 | EP1096017A2 Method for increasing the production of physiologically active substances by cultured cells |
| 05/02/2001 | EP1096016A1 Platelet-activating factor acetylhydrolase |
| 05/02/2001 | EP1096009A1 G-protein coupled receptor-like Polypeptide |
| 05/02/2001 | EP1096008A2 Human G protein-coupled receptor, PFI-014 |
| 05/02/2001 | EP1095154A2 Interaction of human beta amyloid precursor protein (beta-app) with human lon-protease like protein (hslon) |
| 05/02/2001 | EP1095142A2 Molecules associated with cell proliferation |
| 05/02/2001 | EP1095140A2 Neurotrophic factors |
| 05/02/2001 | EP1095135A2 Protein secretion from bacteria having reduced expression of a product encoded by the dlt operon |
| 05/02/2001 | EP1095060A1 Galectin 11 |
| 05/02/2001 | CN1293250A Epidermal growth factor like protein and polynucleotide sequence for coding it |
| 05/02/2001 | CN1293207A Fusion protein with improved combining activity to target cell receptor |
| 05/02/2001 | CN1293204A Polypeptide-human bromo-functional protein 72 and polynucleotide for coding this polypeptide |
| 05/02/2001 | CN1293203A Polypeptide-human zinc finger protein 59 and polynucleotide for coding this polypeptide |
| 05/01/2001 | US6225526 Particularly from spinacia oleracea; transgenic plant cell |
| 05/01/2001 | US6225457 Polynucleotide sequences associated with bacterial proteins; for detection of bactericides |
| 05/01/2001 | US6225455 Constructs for producing phosphorylated fusion proteins |
| 05/01/2001 | US6225449 Hormone analogs with multiple CTP extensions |
| 05/01/2001 | US6225286 Cell surface protein expressed on human cortical thymocyte and their use |
| 05/01/2001 | US6225285 Semaphorin K1 |
| 05/01/2001 | US6225117 Antibodies against human IL-12 |
| 05/01/2001 | US6225112 Human p27Kip1 gene promoter |
| 05/01/2001 | US6225102 Amino acid sequence of guanosine triphosphatase from streptococcus; diagnosis; prophylaxis; drug screening; bactericides; bacteriostats |
| 05/01/2001 | US6225098 UDP-N-acetylenolpyruvyglucosamine reductase |
| 05/01/2001 | US6225087 Polynucleotide which codes for a polypeptide of defined amino acid sequence; drug screening of bactericides against streptococcus; otitis media; conjunctivitis; pneumonia; meningitis; sinusitis; pleural empyema; endocarditis |
| 05/01/2001 | US6225085 Nucleotide and amino acid sequence of leucine-rich surface glycoprotein; diagnosis; prophylaxis; therapy; drug screening; fusion proteins; antigenic peptides; antibodies; recombinant production |
| 05/01/2001 | US6225083 Nucleotide and amino acid sequences of membrane protein involved in cell division; drug screening; bactericides; bacteriostats; antibiotics; for meningitis, sinusitis, conjunctivitis, otitis media, and endocarditis |
| 05/01/2001 | US6225073 Immunoassay for mycophenolic acid |
| 05/01/2001 | US6225060 Includes selectable marker gene, promoter, transcription termination sequence, nucleotide sequence that encodes a tag, and a cloning site; for determining function of foreign genetic material by transfection into a host |
| 05/01/2001 | US6225054 Compositions and methods for the treatment and diagnosis of breast cancer |
| 05/01/2001 | US6225042 Culturing genetically engineered, antigen presenting insect cell line so that major histocompatibility class i molecules bound to selected peptide are produced on surface of cell, then contacting with cd8 t cells |
| 05/01/2001 | US6224881 DNA molecule fragments encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 05/01/2001 | US6224879 Genetic engineering |
| 05/01/2001 | US6224870 Administering a nucleic acid |
| 05/01/2001 | US6224869 Isolated polypeptide |
| 05/01/2001 | US6224868 Reagent and processes for targeting mutant epidermal growth factor receptors |
| 05/01/2001 | CA2324651A1 Split spool type flexible coupling |
| 05/01/2001 | CA2140624C P53 vaccine |
| 05/01/2001 | CA2067333C Production of genetically-engineered vaccines for aids and retroviral diseases |
| 05/01/2001 | CA2046303C Il-1 biological activity inhibitors |
| 05/01/2001 | CA1341226C Gene replacement as a tool for the construction of aspergillus strains |
| 05/01/2001 | CA1341223C Dna clone of human tissue factor inhibitor |
| 05/01/2001 | CA1341222C Preparations of islet amyloid polypeptide (iapp) and antibodies to iapp |
| 05/01/2001 | CA1341220C Cloning and characterization of the bovine interleukin-2-gene |
| 05/01/2001 | CA1341219C Site specific mutagenesis in alpha-1-antitrypsin |
| 04/26/2001 | WO2001029564A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | WO2001029256A2 Cephalic pain susceptibility marker |
| 04/26/2001 | WO2001029255A2 Diagnostic test for cephalic pain |
| 04/26/2001 | WO2001029220A2 Mage-a12 antigenic peptides and uses thereof |
| 04/26/2001 | WO2001029218A2 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 04/26/2001 | WO2001029213A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 04/26/2001 | WO2001029207A1 Antiuracil monoclonal antibody |
| 04/26/2001 | WO2001029204A2 Protein production system |
| 04/26/2001 | WO2001029197A2 Novel germinal center kinase cell cycle proteins, compositions and methods of use |
| 04/26/2001 | WO2001029178A2 Epo primary response gene 1, eprg1 |
| 04/26/2001 | WO2001029072A2 P15paf cell cycle proteins associated with pcna, compositions and methods of use |
| 04/26/2001 | WO2001029063A2 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | WO2001028353A2 Protein hydrolysates produced with the use of marine proteases |
| 04/26/2001 | WO2001028342A1 Oligodendrocyte cell cultures and methods for their preparation and use |
| 04/26/2001 | WO2001005970A3 Gtp-binding protein associated factors |
| 04/26/2001 | WO2000078444A3 Method and device for carrying out biochemical reactions with a high throughput |
| 04/26/2001 | WO2000077040A3 Human intracellular signaling molecules |
| 04/26/2001 | WO2000071723A3 Methods for regulating protein conformation using molecular chaperones |
| 04/26/2001 | WO2000066753A3 Modified vitamin k-dependent polypeptides |
| 04/26/2001 | WO2000061612A3 Compounds and methods for therapy and diagnosis of lung cancer |
| 04/26/2001 | WO2000056889A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/26/2001 | US20010000488 Transforming the host cell with nucleic acid encoding the polypeptide factor, transforming host cell with nucleic acid coding desired protein and culturing the transformed host cell in a medium lacking the polypeptide factor |
| 04/26/2001 | CA2387991A1 Production of protein in insect larvae using a transposon-based expression system |
| 04/26/2001 | CA2387864A1 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 04/26/2001 | CA2387731A1 P15paf cell cycle proteins associated with pcna, compositions and methods of use |
| 04/26/2001 | CA2387041A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 04/26/2001 | CA2386922A1 Novel polypeptides and polynucleotides encoding same |
| 04/26/2001 | CA2386596A1 Novel germinal center kinase cell cycle proteins, compositions and methods of use |
| 04/26/2001 | CA2384841A1 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | CA2384264A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | CA2324385A1 Method for increasing the production of physiologically active substances by cultured cells |